138 related articles for article (PubMed ID: 1891177)
1. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H
Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277
[TBL] [Abstract][Full Text] [Related]
3. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
4. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
5. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
6. Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.
Musch E; Malek M; Peter-Katalinic J; Egge H; Rink H; Lathan B; Riedel E
Cancer Chemother Pharmacol; 1992; 29(4):297-304. PubMed ID: 1537076
[TBL] [Abstract][Full Text] [Related]
7. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and cell-biological investigation of prednimustine compared to its components chlorambucil and prednisolone.
Musch E; Loos U; Alléra A; Hügl E; Pütz I; Malek M
J Chemother; 1989 Jul; 1(4 Suppl):1127-9. PubMed ID: 16312803
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
13. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
14. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
15. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
16. Mammary tumour inhibition and subacute toxicity in rats of prednimustine and of its molecular components chlorambucil and prednisolone.
Fredholm B; Gunnarsson K; Jensen G; Müntzing J
Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):159-63. PubMed ID: 580343
[TBL] [Abstract][Full Text] [Related]
17. Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisolone, and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Semin Oncol; 1986 Mar; 13(1 Suppl 1):8-13. PubMed ID: 3952521
[TBL] [Abstract][Full Text] [Related]
18. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
19. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
[TBL] [Abstract][Full Text] [Related]
20. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]